Close

22nd Century Group (XXII) Enters Research Agreement With the University of Virginia

December 20, 2016 9:52 AM EST Send to a Friend
22nd Century Group, Inc. (NYSE:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login